Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascites

Aliment Pharmacol Ther. 2020 Sep;52(5):885-886. doi: 10.1111/apt.15982.

Authors

Sara Mahgoub¹, Matthew J Armstrong^{1

2}, James W Ferguson^{1

2}

Affiliations

¹ Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² Institute of Immunology and Immunotherapy, National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.

PMID: 32852822
DOI: 10.1111/apt.15982

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-Antagonists
Ascites* / etiology
Humans
Liver Cirrhosis / complications
Liver Cirrhosis / diagnosis
Outpatients*

Substances

Adrenergic beta-Antagonists